Cargando…

Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer

Bladder cancer (BLCA), originating from the epithelium of the urinary bladder, was the second most common malignancy in the urinary system with a high metastasis rate and poor post-metastasis prognosis. Alternative splicing events (ASEs) were regarded as important markers of tumor progression and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Runzhi, Zheng, Zixuan, Xian, Shuyuan, Zhang, Jiayao, Jia, Jingyi, Song, Dianwen, Yan, Penghui, Yin, Huabin, Hu, Peng, Zhu, Xiaolong, Huang, Zongqiang, Meng, Tong, Zhang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806927/ https://www.ncbi.nlm.nih.gov/pubmed/34402716 http://dx.doi.org/10.1080/21655979.2021.1964252

Ejemplares similares

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma
por: Huang, Runzhi, et al.
Publicado: (2022)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Evaluating and Predicting the Probability of Death in Patients with Non-Metastatic Osteosarcoma: A Population-Based Study
por: Huang, Runzhi, et al.
Publicado: (2019)

The Construction of Bone Metastasis-Specific Prognostic Model and Co-expressed Network of Alternative Splicing in Breast Cancer
por: Huang, Runzhi, et al.
Publicado: (2020)

The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma
por: Huang, Runzhi, et al.
Publicado: (2019)

The construction and analysis of tumor-infiltrating immune cells and ceRNA networks in metastatic adrenal cortical carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma
por: Huang, Runzhi, et al.
Publicado: (2019)

Construction and validation of nomograms for non-metastatic Ewing sarcoma: A prognostic factor analysis based on the SEER database
por: Huang, Runzhi, et al.
Publicado: (2021)

The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma With Bone Metastasis
por: Huang, Runzhi, et al.
Publicado: (2019)

Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Prostate Cancer
por: Zhuang, Juanwei, et al.
Publicado: (2022)

Collagen Type III Alpha 1 chain regulated by GATA‐Binding Protein 6 affects Type II IFN response and propanoate metabolism in the recurrence of lower grade glioma
por: Huang, Runzhi, et al.
Publicado: (2020)

Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis
por: Huang, Runzhi, et al.
Publicado: (2021)

Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma
por: Huang, Runzhi, et al.
Publicado: (2021)

The role of toll-like receptors (TLRs) in pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022)

Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population
por: Zhu, Xiaolong, et al.
Publicado: (2021)

The Integrated Transcriptome Bioinformatics Analysis Identifies Key Genes and Cellular Components for Spinal Cord Injury-Related Neuropathic Pain
por: Huang, Runzhi, et al.
Publicado: (2020)

Construction of the prognostic enhancer RNA regulatory network in osteosarcoma
por: Yan, Penghui, et al.
Publicado: (2022)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

The role of tetraspanins pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022)

Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma
por: Guo, Hongjun, et al.
Publicado: (2021)

The Roles of Magnetic Resonance-Guided Focused Ultrasound in Pain Relief in Patients With Bone Metastases: A Systemic Review and Meta-Analysis
por: Han, Xiaying, et al.
Publicado: (2021)

Research hotspots and trends of chordoma: A bibliometric analysis
por: Gao, Jianxuan, et al.
Publicado: (2022)

Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme
por: Huang, Runzhi, et al.
Publicado: (2020)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non‐Metastatic Chondrosarcoma from the SEER Database
por: Huang, Runzhi, et al.
Publicado: (2019)

Identification of Key eRNAs for Spinal Cord Injury by Integrated Multinomial Bioinformatics Analysis
por: Huang, Runzhi, et al.
Publicado: (2021)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer
por: Huang, Runzhi, et al.
Publicado: (2020)

The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma
por: Li, Jin, et al.
Publicado: (2023)

Prognostic Bone Metastasis-Associated Immune-Related Genes Regulated by Transcription Factors in Mesothelioma
por: Hao, Zhiquan, et al.
Publicado: (2022)

Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic Review
por: Meng, Tong, et al.
Publicado: (2019)

Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis
por: Huang, Runzhi, et al.
Publicado: (2022)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer
por: Jbara, Amina, et al.
Publicado: (2023)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Bibliometric analysis of research on gene expression in spinal cord injury
por: Wang, Siqiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ntb4c6ega7nu0n4ii17mfah1u